Den europeiske union - norsk - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunsuppressive - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Norge - norsk - Statens legemiddelverk

hexal a/s - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg

Norge - norsk - Statens legemiddelverk

orion corporation - espoo - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg

Norge - norsk - Statens legemiddelverk

medical valley invest ab - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg

Norge - norsk - Statens legemiddelverk

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 1.25 mg

Norge - norsk - Statens legemiddelverk

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 2.5 mg

Norge - norsk - Statens legemiddelverk

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 5 mg

Norge - norsk - Statens legemiddelverk

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 10 mg

Norge - norsk - Statens legemiddelverk

vitabalans oy - bisoprololfumarat - tablett - 10 mg

Norge - norsk - Statens legemiddelverk

vitabalans oy - bisoprololfumarat - tablett - 5 mg